Topchoice Medical Co., Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
46.74 | 41.44 | 12.79% | 105.9 | -55.87% |
| P/S |
|
8.22 | 20.2 | -59.32% |
|
|
| P/BV |
|
5.67 | 3.68 | 54.29% |
|
|
| P/FCF |
|
93.78 | 82.02 | 14.34% |
|
|
| Ev/Ebitda |
|
40.24 | 16.62 | 142.06% |
|
|
| Ev/S |
|
11.18 | 25.64 | -56.42% |
|
|
| Ev/FCF |
|
95.1 | 85.08 | 11.78% |
|
|
| E/P |
|
0.016 | 0.0217 | -26.2% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
35.36 | 6.32 | 459.3% | 36.02 | -1.84% |
| ROE |
|
14.07 | 6.65 | 111.45% |
|
|
| ROA |
|
8.97 | 3.59 | 150.1% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
17.58 | -76.75 | -122.91% |
|
|
| ROCE |
|
0 | 19.43 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.47 | 0.7406 | 98.06% | 1.31 | +11.64% |
| Nеt Debt/Ebitda |
|
0 | -0.1122 | -100% |
|
|
| Debt/Ratio |
|
0.2348 | 0.1008 | 132.84% |
|
|
| Debt/Equity |
|
1.27 | 0.212 | 499.29% |
|
|
| Debt/Net Income |
|
2.82 | 1.37 | 105% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.3975 | -100% | 0.2744 | -100% |
| Number of years of dividend growth |
|
0 | 0.9885 | -100% | ||
| DSI |
|
0.5 | 0.6935 | -27.9% |
|
|
| Average dividend growth |
|
-166.67 | 2.08 | -8097.57% |
|
|
| Average percentage for 5 years |
|
0.2744 | 1.4 | -80.34% |
|
|
| Average percentage for payments |
|
9.2 | 45.07 | -79.59% |
|
|
| Difference from average difference in sector |
|
-0.3975 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
7/10
|
50.27 | 23.95 | 109.9% | ||
| Growth impulse Ebitda in 5 years |
|
10.43 | 12.85 | -18.83% | ||
| Growth impulse Net Income in 5 years |
|
8.08 | 62.77 | -87.13% | ||
| Growth impulse FCF in 5 years |
|
-35.92 | 30.35 | -218.35% | ||
| Growth impulse EPS in 5 years |
|
-22.61 | 82.9 | -127.27% |
IP Score
3.74/10
